Showing 1 - 10 of 16
Aim: To evaluate the costs and effectiveness of on-demand maintenance therapy with oral esomeprazole, lansoprazole, omeprazole, pantoprazole or rabeprazole in patients with endoscopy-confirmed non-erosive reflux disease (NERD) in the UK. Methods: A probabilistic model was developed to compare...
Persistent link: https://www.econbiz.de/10005404806
Background: Knee cartilage lesions increase the risk of developing osteoarthritis (OA), and may eventually result in a total knee replacement (TKR). There is currently no consensus on the optimal treatment of cartilage lesions. ChondroCelect (CC) is a cell-based therapy approved for use in...
Persistent link: https://www.econbiz.de/10008725815
Background: Chronic osteoarthritis (OA) pain impacts health-related quality of life (HR-QOL). Objective: The primary aim of this study was to evaluate and compare HR-QOL outcomes following treatment with once-daily push-pull Osmotic controlled-Release Oral delivery System (OROS) hydromorphone...
Persistent link: https://www.econbiz.de/10005404582
Persistent link: https://www.econbiz.de/10011317762
Persistent link: https://www.econbiz.de/10009780660
Persistent link: https://www.econbiz.de/10011005459
Background and Objectives:Background and Objectives: Economic value is an important consideration during all phases of the drug development process. We previously published an article in PharmacoEconomics in which we described a mechanism-based economic modelling approach that incorporates data...
Persistent link: https://www.econbiz.de/10010541098
Persistent link: https://www.econbiz.de/10010614367
Persistent link: https://www.econbiz.de/10010144919
Cost estimates for the drug of interest, its comparator and concomitant drugs are an important component of pharmacoeconomic evaluations. However, whilst in general considerable efforts are made by analysts to ensure valid and accurate parameter inputs, the methods for estimating drug costs are...
Persistent link: https://www.econbiz.de/10004969762